Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IGHID 11705 A Randomized, Open-label, Controlled Clinical Trial to Assess the Efficacy of F598 in Preventing an Experimental Urethral Infection With Neisseria Gonorrhoeae in Healthy Male Subjects

NCT03222401 is registered in ClinicalTrials.gov with Alopexx Pharmaceuticals, LLC as lead sponsor.

NCT NCT03222401
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03222401 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IGHID 11705 A Randomized, Open-label, Controlled Clinical Trial to Assess the Efficacy of F598 in Preventing an Experimental Urethral Infection With Neisseria Gonorrhoeae in Healthy Male Subjects
Lead sponsor
Alopexx Pharmaceuticals, LLC
Phase
Phase 2
Overall status
Terminated
Start date
November 29, 2017
Completion date
March 2, 2018
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neisseria gonorrhoeae